- Experimental drug takes new approach to schizophrenia | Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02190-6/fulltext 6 comments futurology